Rocket Lab (RKLB) Delivers Record Revenue but Misses EPS Target in Q2 2026
Key Takeaways
- Record quarterly revenue of $234.07 million, up 62% year-over-year, narrowly surpassing consensus estimates of approximately $231.6 million.
- GAAP loss per share of $0.08 missed the consensus estimate of a $0.06 loss, driven in part by acquisition-related transaction costs.
- Backlog reached an all-time high of $2.36 billion, surging 137% from the year-ago period, with more than $1 billion in new contracts already signed in the first weeks of Q3.
- Adjusted EBITDA loss narrowed to $8.8 million from $27.6 million a year earlier, significantly outperforming management's own guidance range.
- Neutron rocket development remains on schedule for pad delivery in Q4 2026, though CEO Peter Beck noted the window for a year-end maiden launch is narrowing.
- Shares declined roughly 2% to 6% in after-hours trading as the earnings miss and softer near-term margin guidance tempered enthusiasm around record top-line growth.
Why This Quarter Matters
Rocket Lab's Q2 2026 report arrives at a pivotal moment for the end-to-end space company. The stock had already pulled back roughly 45% from its May 2026 high near $151, reflecting broader investor re-pricing across high-growth, high-valuation space names. At more than 65 times trailing sales, Rocket Lab entered this earnings print with little room for error. The quarter also represents the first reporting period incorporating the closed acquisitions of Mynaric and Motiv, adding new revenue streams and cost dynamics. Meanwhile, the pending $8 billion acquisition of Iridium Communications — announced in June and expected to close in mid-2027 — continues to reshape the long-term narrative. Investors were scrutinizing whether Rocket Lab could sustain its remarkable growth trajectory while demonstrating a credible path toward profitability.
Q2 Results in Detail
Rocket Lab reported Q2 2026 revenue of $234.07 million, a 62% increase from $144.5 million in the same quarter last year and a new company record, exceeding the $231.6 million consensus estimate. Product revenue surged 96% year-over-year to $181.3 million, while service revenue contributed $52.7 million. Space Systems generated $189.5 million, and Launch Services added $44.6 million.
On the bottom line, the company posted a GAAP net loss of $49.3 million, or $0.08 per share, improving from a loss of $66.4 million, or $0.13 per share, a year earlier. However, the per-share result missed the consensus estimate of a $0.06 loss, with the gap largely attributable to $8.6 million in transaction costs tied to the Mynaric and Motiv acquisitions and the pending Iridium deal.
Profitability metrics showed encouraging momentum. Adjusted EBITDA loss narrowed sharply to $8.8 million from $27.6 million in Q2 2025, dramatically outperforming management's guidance range of a $20 million to $26 million loss. GAAP gross margin reached 36.1%, exceeding guidance of 33% to 35%, while non-GAAP gross margin of 41.5% surpassed the 38% to 40% guidance range. The company ended the quarter with $2.13 billion in cash and cash equivalents, providing substantial financial runway.
The backlog surged to a record $2.36 billion, up 137% year-over-year, with the launch backlog exceeding 90 missions — the highest in company history. Management disclosed that, combined with post-quarter signings, Rocket Lab has already booked more than $1 billion in new contracts across launch and space systems in Q3 to date.
From what I see, the backlog expansion stands out as particularly important because it signals sustained demand even as the company integrates recent acquisitions.
Market Reaction and Investor Sentiment
Despite delivering record revenue and backlog figures, Rocket Lab shares fell between 2% and 6% in after-hours trading on Monday. The decline reflected a mixed reception: while the top-line beat and order-book expansion validated the company's demand story, the wider-than-expected per-share loss and forward margin guidance disappointed investors conditioned to expect flawless execution at the stock's elevated valuation multiple.
Investor sentiment entering the print had been cautiously optimistic, with options market data showing a bullish skew and a put-to-call ratio of 0.58 on near-dated contracts. The stock had rallied more than 40% from its late-July lows ahead of the report. However, the after-hours slide suggests that for a company trading at over 65 times trailing revenue, even a record quarter can fall short of market expectations when profitability concerns persist. CEO Peter Beck's acknowledgment that the Neutron launch window is "narrowing" added an additional layer of uncertainty that likely contributed to the cautious post-earnings tone.
Forward Outlook and Key Factors to Monitor
Rocket Lab issued Q3 2026 revenue guidance of $250 million to $265 million — the midpoint of $257.5 million easily exceeding the analyst consensus of approximately $235.9 million and representing year-over-year growth of around 66%. This would mark the company's sixth consecutive record revenue quarter.
However, profitability guidance came in softer than anticipated. Management expects GAAP gross margins of 29% to 31% and non-GAAP gross margins of 35% to 37%, both below the Q2 results, reflecting a shift toward lower-margin satellite platform work. The adjusted EBITDA loss is projected at $17 million to $23 million — wider than some analysts had modeled. The sequential margin compression appears tied to product mix dynamics and continued investment in the Neutron program.
The Neutron medium-lift reusable rocket remains the single most important catalyst on the horizon. Stage 1 tank production is aligned with pad delivery in Q4 2026, and the Archimedes engine program has completed more than 400 hot-fire tests. Yet Beck's caution about the narrowing launch window introduces the real possibility that the maiden flight could slide into 2027. Any further timeline adjustments would likely weigh on sentiment, given that major contract wins — including the $397 million Space Force SB-AMTI award — depend on Neutron becoming operational.
Beyond Neutron, the Iridium acquisition looms as a transformative event. Expected to close in mid-2027, the deal would add an operational 66-satellite constellation, over 2.5 million subscribers, and more than $870 million in annual revenue, positioning Rocket Lab as a vertically integrated space communications provider. Meanwhile, investors should monitor backlog conversion rates, the ramp-up of GHOST containerized launch operations in Alaska by 2027, and the integration of Mynaric and Motiv, which are expected to expand the company's space systems capabilities.
I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry.
AI Tools in My Research Workflow
In my analysis of high-growth sectors like aerospace, I often turn to Tickeron's AI-powered platforms to cross-reference fundamentals and technical signals. One tool that has proven useful is the AI Trend Prediction Engine, which helps surface potential momentum shifts based on historical patterns and current data. These resources allow me to quickly validate ideas without sifting through endless spreadsheets, keeping the focus on what actually moves the needle for long-term positioning.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
RKLB's RSI Indicator climbs out of oversold territory
The RSI Indicator for RKLB moved out of oversold territory on September 02, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 29 of the 32 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for RKLB crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
Following a +6.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in 260 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RKLB as a result. In 65 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Moving Average Convergence Divergence Histogram (MACD) for RKLB turned negative on October 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 32 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
RKLB moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
RKLB broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for RKLB entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. RKLB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.210) is normal, around the industry mean (6.305). P/E Ratio (27.472) is within average values for comparable stocks, (58.116). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.564). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (48.309) is also within normal values, averaging (18.330).
The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry AerospaceDefense
Advertisement